Rebecca Jean Jones, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 335 Cardinal Rd, Louisa, VA 23093 Phone: 321-408-0951 |
Rosemary Cosselmon, LPC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 101 Ashley Street, Louisa, VA 23093 Phone: 540-967-2880 |
Mr. Steven Michael Whetzel, MA PSYCHOLOGIST Counselor - Pastoral Medicare: Not Enrolled in Medicare Practice Location: 2109 S Lakeshore Dr, Louisa, VA 23093 Phone: 540-967-3891 Fax: 540-967-3891 |
Nathan Newcomb Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 202 W Main St, Louisa, VA 23093 Phone: 540-894-7263 |
Ms. Kendall Marie Britt, LCSWW Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 101 Ashley St, Louisa, VA 23093 Phone: 540-967-2880 |
News Archive
If you thought the best way to lose and maintain weight was the slow and steady approach, think again. A new study by Lisa Nackers and colleagues, from the University of Florida in the US, suggests that the key to long-term weight loss and maintenance is to lose weight quickly, not gradually, in the initial stages of obesity treatment. Their findings1 are published online in Springer's International Journal of Behavioral Medicine.
Chromatrap®, a business unit of Porvair Sciences, has produced a new 10-page brochure that provides an informative introduction to chromatin immunoprecipitation (ChIP) technology and a detailed comparison of traditional bead based and Chromatrap® solid state ChIP technologies.
New research shows genes that make smokers more likely to develop chronic obstructive pulmonary disease (COPD), or emphysema, are also closely linked to an increased likelihood of developing lung cancer, according to studies presented today at the American Thoracic Society's annual meeting.
U.S. Senate Committee on Small Business and Entrepreneurship Chair Mary L. Landrieu, D-La., today commented on the President's signing of the Patient Protection and Affordable Care Act. The Act, passed by the U.S. House of Representatives Sunday evening, lowers costs and increases choices and stability for small businesses.
Through a series of investigations in mice and humans, Johns Hopkins researchers have identified a protein that appears to be the target of both antidepressant drugs and electroconvulsive therapy. Results of their experiments explain how these therapies likely work to relieve depression by stimulating stem cells in the brain to grow and mature.
› Verified 1 days ago